A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
Seema N. Sanghavi, Michael N. Needle, Mark D. Krailo, J. Russell Geyer, Joann Ater, and Minesh P. Mehta
Neuro Oncol. 2003 January; 5(1): 8–13. PMCID: PMC1920667